Skip to main content

Conjunctivitis News

FDA Medwatch Alert: FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

September 12, 2023 – The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal...

Now Available Over the Counter, Lastacaft Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours

Itchy allergy eyes affect an estimated 40% of Americans1 Lastacaft is a once-daily eye drop that works within minutes against seasonal and year-round allergens to relieve itchy eyes Previously...

Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%

Sophia Antipolis, France, May 31, 2017 – Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that the U.S. Food and Drug Administration (FDA)...

Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis

Basel, Switzerland, February 2, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received approval from the U.S. Food and Drug Administration (FDA) of Pazeo (olopatadine h...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Keratoconjunctivitis Sicca, Eye Conditions

Related drug support groups

triamcinolone, cortisone